Novo Nordisk named one of JPMorgan's preferred pharma stocks in 2023 — MedWatch
Novo Nordisk Pharmatech A/S - Cell 2023
Novo Nordisk | Contract Pharma
Novo Nordisk recruits, lays off staff in Boston expansion
Ventus and Novo Nordisk enter NLRP3 inhibitor development deal
Wegovy, the newest weight loss drug, comes with a high cost - Los Angeles Times
Novo Nordisk: This Winner Has Risks, Be Aware (NYSE:NVO) | Seeking Alpha
Novo Nordisk : Top 25 Pharma & BioPharma in 2021 | Contract Pharma
Novo Nordisk Pharmatech A/S - European Pharmaceutical Manufacturer
Novo Nordisk to build €70m plant in Iran | Financial Times
Novo Nordisk (@novonordisk) / Twitter
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
Denmark's Novo Nordisk to buy Dicerna Pharma for $3.3 billion | Reuters
Who we are
Novo Nordisk | LinkedIn
Novo Nordisk leads pharma pack breaking into Reputation Institute's corporate responsibility ranking | Fierce Pharma
Novo Nordisk Pharmatech - Pharma Technology Focus | Yearbook 2018
